Centre Caps Trade Margins on Cancer Drugs at 30%, Patients May Save ₹2,500 Crore Annually
NEW DELHI, Oct 10: The Centre's decision to cap trade margins on non-scheduled anti-cancer medicines at 30 per cent is expected to…
Independent , Honest and Dignified Journalism